Mutation of the galectin‐3 glycan‐binding domain (Lgals3‐R200S) enhances cortical bone expansion in male mice and trabecular bone mass in female mice
We previously observed that genomic loss of galectin‐3 (Gal‐3; encoded by Lgals3) in mice has a significant protective effect on age‐related bone loss. Gal‐3 has both intracellular and extracellular functionality, and we wanted to assess whether the affect we observed in the Lgals3 knockout (KO) mic...
Main Authors: | Kevin A. Maupin, Cassandra R. Diegel, Payton D. Stevens, Daniel Dick, VAI Vivarium and Transgenic Core, Bart O. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.13483 |
Similar Items
-
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
by: Yan Lv, et al.
Published: (2023-11-01) -
Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study
by: Eudes Gustavo Constantino Cunha, et al.
Published: (2021-05-01) -
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01) -
Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01) -
The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)